nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethotoin—SCN10A—skin cancer	0.844	1	CbGaD
Ethotoin—Non-Hodgkin's lymphoma—Imiquimod—skin cancer	0.00638	0.0862	CcSEcCtD
Ethotoin—Lymphoma—Imiquimod—skin cancer	0.00638	0.0862	CcSEcCtD
Ethotoin—SCN7A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00544	0.0818	CbGpPWpGaD
Ethotoin—SCN11A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00485	0.0729	CbGpPWpGaD
Ethotoin—SCN8A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00443	0.0667	CbGpPWpGaD
Ethotoin—SCN9A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00359	0.0539	CbGpPWpGaD
Ethotoin—SCN11A—nerve—skin cancer	0.00359	0.219	CbGeAlD
Ethotoin—SCN3A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00343	0.0516	CbGpPWpGaD
Ethotoin—SCN4A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00329	0.0496	CbGpPWpGaD
Ethotoin—SCN2A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00329	0.0496	CbGpPWpGaD
Ethotoin—SCN1A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00318	0.0478	CbGpPWpGaD
Ethotoin—Emotional distress—Fluorouracil—skin cancer	0.0029	0.0391	CcSEcCtD
Ethotoin—SCN8A—nerve—skin cancer	0.00272	0.166	CbGeAlD
Ethotoin—SCN5A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00223	0.0336	CbGpPWpGaD
Ethotoin—SCN7A—L1CAM interactions—SCN10A—skin cancer	0.00209	0.0314	CbGpPWpGaD
Ethotoin—Lymphadenopathy—Imiquimod—skin cancer	0.0019	0.0256	CcSEcCtD
Ethotoin—SCN11A—L1CAM interactions—SCN10A—skin cancer	0.00186	0.028	CbGpPWpGaD
Ethotoin—SCN10A—nerve—skin cancer	0.00182	0.111	CbGeAlD
Ethotoin—Nystagmus—Fluorouracil—skin cancer	0.00172	0.0233	CcSEcCtD
Ethotoin—SCN8A—L1CAM interactions—SCN10A—skin cancer	0.0017	0.0256	CbGpPWpGaD
Ethotoin—Systemic lupus erythematosus—Docetaxel—skin cancer	0.0016	0.0217	CcSEcCtD
Ethotoin—Numbness—Fluorouracil—skin cancer	0.00148	0.0201	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00145	0.0196	CcSEcCtD
Ethotoin—Sensory loss—Fluorouracil—skin cancer	0.00142	0.0192	CcSEcCtD
Ethotoin—SCN9A—L1CAM interactions—SCN10A—skin cancer	0.00138	0.0207	CbGpPWpGaD
Ethotoin—SCN3A—L1CAM interactions—SCN10A—skin cancer	0.00132	0.0198	CbGpPWpGaD
Ethotoin—Fatigue—Vismodegib—skin cancer	0.0013	0.0176	CcSEcCtD
Ethotoin—SCN2A—L1CAM interactions—SCN10A—skin cancer	0.00126	0.019	CbGpPWpGaD
Ethotoin—SCN4A—L1CAM interactions—SCN10A—skin cancer	0.00126	0.019	CbGpPWpGaD
Ethotoin—Erythema multiforme—Vemurafenib—skin cancer	0.00124	0.0168	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00124	0.0167	CcSEcCtD
Ethotoin—SCN1A—L1CAM interactions—SCN10A—skin cancer	0.00122	0.0183	CbGpPWpGaD
Ethotoin—Asthenia—Vismodegib—skin cancer	0.00108	0.0146	CcSEcCtD
Ethotoin—Erythema multiforme—Imiquimod—skin cancer	0.00106	0.0143	CcSEcCtD
Ethotoin—Diarrhoea—Vismodegib—skin cancer	0.00103	0.014	CcSEcCtD
Ethotoin—Diplopia—Temozolomide—skin cancer	0.00097	0.0131	CcSEcCtD
Ethotoin—Vomiting—Vismodegib—skin cancer	0.00096	0.013	CcSEcCtD
Ethotoin—Rash—Vismodegib—skin cancer	0.000952	0.0129	CcSEcCtD
Ethotoin—Dermatitis—Vismodegib—skin cancer	0.000951	0.0128	CcSEcCtD
Ethotoin—Ataxia—Temozolomide—skin cancer	0.000912	0.0123	CcSEcCtD
Ethotoin—Nausea—Vismodegib—skin cancer	0.000897	0.0121	CcSEcCtD
Ethotoin—SCN7A—female reproductive system—skin cancer	0.000866	0.053	CbGeAlD
Ethotoin—SCN5A—L1CAM interactions—SCN10A—skin cancer	0.000857	0.0129	CbGpPWpGaD
Ethotoin—SCN11A—head—skin cancer	0.00085	0.052	CbGeAlD
Ethotoin—Ataxia—Fluorouracil—skin cancer	0.00084	0.0113	CcSEcCtD
Ethotoin—Chest pain—Imiquimod—skin cancer	0.00083	0.0112	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000819	0.0111	CcSEcCtD
Ethotoin—Fatigue—Vemurafenib—skin cancer	0.000804	0.0109	CcSEcCtD
Ethotoin—Hypoaesthesia—Bleomycin—skin cancer	0.000791	0.0107	CcSEcCtD
Ethotoin—SCN7A—Axon guidance—SCN10A—skin cancer	0.000789	0.0119	CbGpPWpGaD
Ethotoin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000741	0.01	CcSEcCtD
Ethotoin—Body temperature increased—Vemurafenib—skin cancer	0.000737	0.00996	CcSEcCtD
Ethotoin—SCN7A—head—skin cancer	0.000723	0.0442	CbGeAlD
Ethotoin—Insomnia—Imiquimod—skin cancer	0.000719	0.00972	CcSEcCtD
Ethotoin—SCN11A—Axon guidance—SCN10A—skin cancer	0.000703	0.0106	CbGpPWpGaD
Ethotoin—Erythema multiforme—Dactinomycin—skin cancer	0.000701	0.00947	CcSEcCtD
Ethotoin—Fatigue—Imiquimod—skin cancer	0.000686	0.00926	CcSEcCtD
Ethotoin—Asthenia—Vemurafenib—skin cancer	0.000669	0.00904	CcSEcCtD
Ethotoin—Hypoaesthesia—Temozolomide—skin cancer	0.000667	0.00902	CcSEcCtD
Ethotoin—SCN8A—head—skin cancer	0.000645	0.0394	CbGeAlD
Ethotoin—SCN8A—Axon guidance—SCN10A—skin cancer	0.000643	0.00967	CbGpPWpGaD
Ethotoin—Diarrhoea—Vemurafenib—skin cancer	0.000638	0.00862	CcSEcCtD
Ethotoin—Erythema multiforme—Temozolomide—skin cancer	0.000634	0.00857	CcSEcCtD
Ethotoin—Body temperature increased—Imiquimod—skin cancer	0.000629	0.00849	CcSEcCtD
Ethotoin—Dizziness—Vemurafenib—skin cancer	0.000617	0.00833	CcSEcCtD
Ethotoin—Hypoaesthesia—Fluorouracil—skin cancer	0.000615	0.00831	CcSEcCtD
Ethotoin—Ataxia—Docetaxel—skin cancer	0.000606	0.00819	CcSEcCtD
Ethotoin—Vomiting—Vemurafenib—skin cancer	0.000593	0.00801	CcSEcCtD
Ethotoin—Chest pain—Bleomycin—skin cancer	0.000589	0.00796	CcSEcCtD
Ethotoin—Rash—Vemurafenib—skin cancer	0.000588	0.00794	CcSEcCtD
Ethotoin—Dermatitis—Vemurafenib—skin cancer	0.000587	0.00794	CcSEcCtD
Ethotoin—Headache—Vemurafenib—skin cancer	0.000584	0.00789	CcSEcCtD
Ethotoin—Asthenia—Imiquimod—skin cancer	0.000571	0.00771	CcSEcCtD
Ethotoin—SCN7A—Developmental Biology—SCN10A—skin cancer	0.000563	0.00847	CbGpPWpGaD
Ethotoin—Nausea—Vemurafenib—skin cancer	0.000554	0.00748	CcSEcCtD
Ethotoin—Diarrhoea—Imiquimod—skin cancer	0.000544	0.00735	CcSEcCtD
Ethotoin—SCN10A—lymphoid tissue—skin cancer	0.000535	0.0327	CbGeAlD
Ethotoin—Dizziness—Imiquimod—skin cancer	0.000526	0.0071	CcSEcCtD
Ethotoin—SCN9A—Axon guidance—SCN10A—skin cancer	0.00052	0.00782	CbGpPWpGaD
Ethotoin—SCN7A—lymph node—skin cancer	0.000506	0.031	CbGeAlD
Ethotoin—Vomiting—Imiquimod—skin cancer	0.000506	0.00683	CcSEcCtD
Ethotoin—SCN4A—head—skin cancer	0.000505	0.0309	CbGeAlD
Ethotoin—SCN11A—Developmental Biology—SCN10A—skin cancer	0.000502	0.00755	CbGpPWpGaD
Ethotoin—Rash—Imiquimod—skin cancer	0.000501	0.00677	CcSEcCtD
Ethotoin—Dermatitis—Imiquimod—skin cancer	0.000501	0.00677	CcSEcCtD
Ethotoin—Headache—Imiquimod—skin cancer	0.000498	0.00673	CcSEcCtD
Ethotoin—SCN3A—Axon guidance—SCN10A—skin cancer	0.000497	0.00748	CbGpPWpGaD
Ethotoin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000493	0.00666	CcSEcCtD
Ethotoin—SCN1A—head—skin cancer	0.000487	0.0298	CbGeAlD
Ethotoin—SCN2A—Axon guidance—SCN10A—skin cancer	0.000478	0.00719	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—SCN10A—skin cancer	0.000478	0.00719	CbGpPWpGaD
Ethotoin—Nausea—Imiquimod—skin cancer	0.000472	0.00638	CcSEcCtD
Ethotoin—SCN3A—female reproductive system—skin cancer	0.00047	0.0288	CbGeAlD
Ethotoin—SCN1A—Axon guidance—SCN10A—skin cancer	0.000461	0.00693	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—SCN10A—skin cancer	0.000459	0.0069	CbGpPWpGaD
Ethotoin—Chest pain—Fluorouracil—skin cancer	0.000458	0.00619	CcSEcCtD
Ethotoin—Fatigue—Dactinomycin—skin cancer	0.000454	0.00614	CcSEcCtD
Ethotoin—SCN7A—Axon guidance—RASA1—skin cancer	0.000453	0.00681	CbGpPWpGaD
Ethotoin—SCN2A—head—skin cancer	0.000447	0.0274	CbGeAlD
Ethotoin—Body temperature increased—Bleomycin—skin cancer	0.000447	0.00603	CcSEcCtD
Ethotoin—Hypoaesthesia—Docetaxel—skin cancer	0.000444	0.006	CcSEcCtD
Ethotoin—SCN10A—head—skin cancer	0.000431	0.0264	CbGeAlD
Ethotoin—Insomnia—Temozolomide—skin cancer	0.000431	0.00582	CcSEcCtD
Ethotoin—Erythema multiforme—Docetaxel—skin cancer	0.000422	0.0057	CcSEcCtD
Ethotoin—Body temperature increased—Dactinomycin—skin cancer	0.000417	0.00563	CcSEcCtD
Ethotoin—Fatigue—Temozolomide—skin cancer	0.000411	0.00555	CcSEcCtD
Ethotoin—Asthenia—Bleomycin—skin cancer	0.000405	0.00548	CcSEcCtD
Ethotoin—SCN11A—Axon guidance—RASA1—skin cancer	0.000404	0.00607	CbGpPWpGaD
Ethotoin—Insomnia—Fluorouracil—skin cancer	0.000397	0.00537	CcSEcCtD
Ethotoin—SCN9A—lymph node—skin cancer	0.000397	0.0243	CbGeAlD
Ethotoin—SCN3A—head—skin cancer	0.000393	0.024	CbGeAlD
Ethotoin—SCN5A—head—skin cancer	0.000392	0.024	CbGeAlD
Ethotoin—Asthenia—Dactinomycin—skin cancer	0.000378	0.00511	CcSEcCtD
Ethotoin—Body temperature increased—Temozolomide—skin cancer	0.000377	0.00509	CcSEcCtD
Ethotoin—SCN9A—Developmental Biology—SCN10A—skin cancer	0.000371	0.00558	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—RASA1—skin cancer	0.000369	0.00555	CbGpPWpGaD
Ethotoin—Diarrhoea—Dactinomycin—skin cancer	0.000361	0.00487	CcSEcCtD
Ethotoin—Vomiting—Bleomycin—skin cancer	0.000359	0.00485	CcSEcCtD
Ethotoin—Rash—Bleomycin—skin cancer	0.000356	0.00481	CcSEcCtD
Ethotoin—Dermatitis—Bleomycin—skin cancer	0.000356	0.00481	CcSEcCtD
Ethotoin—SCN3A—Developmental Biology—SCN10A—skin cancer	0.000355	0.00534	CbGpPWpGaD
Ethotoin—Body temperature increased—Fluorouracil—skin cancer	0.000347	0.00469	CcSEcCtD
Ethotoin—Asthenia—Temozolomide—skin cancer	0.000342	0.00462	CcSEcCtD
Ethotoin—SCN2A—Developmental Biology—SCN10A—skin cancer	0.000341	0.00513	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—SCN10A—skin cancer	0.000341	0.00513	CbGpPWpGaD
Ethotoin—Nausea—Bleomycin—skin cancer	0.000336	0.00453	CcSEcCtD
Ethotoin—Vomiting—Dactinomycin—skin cancer	0.000335	0.00453	CcSEcCtD
Ethotoin—Rash—Dactinomycin—skin cancer	0.000332	0.00449	CcSEcCtD
Ethotoin—Chest pain—Docetaxel—skin cancer	0.000331	0.00447	CcSEcCtD
Ethotoin—SCN1A—Developmental Biology—SCN10A—skin cancer	0.000329	0.00495	CbGpPWpGaD
Ethotoin—Diarrhoea—Temozolomide—skin cancer	0.000326	0.00441	CcSEcCtD
Ethotoin—SCN5A—Axon guidance—SCN10A—skin cancer	0.000324	0.00487	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—RASA1—skin cancer	0.000323	0.00486	CbGpPWpGaD
Ethotoin—Dizziness—Temozolomide—skin cancer	0.000315	0.00426	CcSEcCtD
Ethotoin—Nausea—Dactinomycin—skin cancer	0.000313	0.00423	CcSEcCtD
Ethotoin—Vomiting—Temozolomide—skin cancer	0.000303	0.00409	CcSEcCtD
Ethotoin—SCN10A—lymph node—skin cancer	0.000302	0.0185	CbGeAlD
Ethotoin—Rash—Temozolomide—skin cancer	0.0003	0.00406	CcSEcCtD
Ethotoin—Diarrhoea—Fluorouracil—skin cancer	0.0003	0.00406	CcSEcCtD
Ethotoin—Dermatitis—Temozolomide—skin cancer	0.0003	0.00406	CcSEcCtD
Ethotoin—SCN9A—Axon guidance—RASA1—skin cancer	0.000299	0.00449	CbGpPWpGaD
Ethotoin—Headache—Temozolomide—skin cancer	0.000299	0.00403	CcSEcCtD
Ethotoin—Dizziness—Fluorouracil—skin cancer	0.00029	0.00392	CcSEcCtD
Ethotoin—SCN11A—Developmental Biology—RASA1—skin cancer	0.000288	0.00433	CbGpPWpGaD
Ethotoin—Insomnia—Docetaxel—skin cancer	0.000287	0.00387	CcSEcCtD
Ethotoin—SCN3A—Axon guidance—RASA1—skin cancer	0.000286	0.0043	CbGpPWpGaD
Ethotoin—Nausea—Temozolomide—skin cancer	0.000283	0.00382	CcSEcCtD
Ethotoin—Vomiting—Fluorouracil—skin cancer	0.000279	0.00377	CcSEcCtD
Ethotoin—Rash—Fluorouracil—skin cancer	0.000277	0.00374	CcSEcCtD
Ethotoin—Dermatitis—Fluorouracil—skin cancer	0.000277	0.00374	CcSEcCtD
Ethotoin—SCN3A—lymph node—skin cancer	0.000275	0.0168	CbGeAlD
Ethotoin—Headache—Fluorouracil—skin cancer	0.000275	0.00372	CcSEcCtD
Ethotoin—SCN4A—Axon guidance—RASA1—skin cancer	0.000274	0.00413	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—RASA1—skin cancer	0.000274	0.00413	CbGpPWpGaD
Ethotoin—Fatigue—Docetaxel—skin cancer	0.000273	0.00369	CcSEcCtD
Ethotoin—SCN1A—Axon guidance—RASA1—skin cancer	0.000265	0.00398	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—RASA1—skin cancer	0.000265	0.00398	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—RASA1—skin cancer	0.000264	0.00396	CbGpPWpGaD
Ethotoin—Nausea—Fluorouracil—skin cancer	0.000261	0.00352	CcSEcCtD
Ethotoin—Body temperature increased—Docetaxel—skin cancer	0.000251	0.00338	CcSEcCtD
Ethotoin—SCN5A—Developmental Biology—SCN10A—skin cancer	0.000231	0.00348	CbGpPWpGaD
Ethotoin—Asthenia—Docetaxel—skin cancer	0.000227	0.00307	CcSEcCtD
Ethotoin—Diarrhoea—Docetaxel—skin cancer	0.000217	0.00293	CcSEcCtD
Ethotoin—SCN9A—Developmental Biology—RASA1—skin cancer	0.000213	0.00321	CbGpPWpGaD
Ethotoin—Dizziness—Docetaxel—skin cancer	0.00021	0.00283	CcSEcCtD
Ethotoin—SCN3A—Developmental Biology—RASA1—skin cancer	0.000204	0.00307	CbGpPWpGaD
Ethotoin—Vomiting—Docetaxel—skin cancer	0.000202	0.00272	CcSEcCtD
Ethotoin—Rash—Docetaxel—skin cancer	0.0002	0.0027	CcSEcCtD
Ethotoin—Dermatitis—Docetaxel—skin cancer	0.0002	0.0027	CcSEcCtD
Ethotoin—Headache—Docetaxel—skin cancer	0.000199	0.00268	CcSEcCtD
Ethotoin—SCN4A—Developmental Biology—RASA1—skin cancer	0.000196	0.00295	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—RASA1—skin cancer	0.000196	0.00295	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—RASA1—skin cancer	0.000189	0.00284	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—RASA1—skin cancer	0.000189	0.00284	CbGpPWpGaD
Ethotoin—Nausea—Docetaxel—skin cancer	0.000188	0.00254	CcSEcCtD
Ethotoin—SCN5A—Axon guidance—RASA1—skin cancer	0.000186	0.0028	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—CDK4—skin cancer	0.000159	0.00238	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—CDK4—skin cancer	0.000141	0.00213	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—RASA1—skin cancer	0.000133	0.002	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—CDK4—skin cancer	0.000129	0.00194	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—NRAS—skin cancer	0.000124	0.00186	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—NRAS—skin cancer	0.00011	0.00166	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—KRAS—skin cancer	0.000106	0.0016	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—CDK4—skin cancer	0.000105	0.00157	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—NRAS—skin cancer	0.000101	0.00151	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—CDK4—skin cancer	0.0001	0.0015	CbGpPWpGaD
Ethotoin—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	9.85e-05	0.00148	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—CDK4—skin cancer	9.6e-05	0.00144	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—CDK4—skin cancer	9.6e-05	0.00144	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—KRAS—skin cancer	9.48e-05	0.00143	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—CDK4—skin cancer	9.26e-05	0.00139	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—CDK4—skin cancer	9.26e-05	0.00139	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—HRAS—skin cancer	9.04e-05	0.00136	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—NRAS—skin cancer	8.82e-05	0.00133	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—KRAS—skin cancer	8.67e-05	0.0013	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—IL6—skin cancer	8.65e-05	0.0013	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—NRAS—skin cancer	8.14e-05	0.00123	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—HRAS—skin cancer	8.05e-05	0.00121	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—NRAS—skin cancer	7.86e-05	0.00118	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—NRAS—skin cancer	7.79e-05	0.00117	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—IL6—skin cancer	7.71e-05	0.00116	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—KRAS—skin cancer	7.59e-05	0.00114	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—NRAS—skin cancer	7.48e-05	0.00113	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—NRAS—skin cancer	7.48e-05	0.00113	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	7.37e-05	0.00111	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—HRAS—skin cancer	7.37e-05	0.00111	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—NRAS—skin cancer	7.22e-05	0.00109	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—NRAS—skin cancer	7.22e-05	0.00109	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—NRAS—skin cancer	7.19e-05	0.00108	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—IL6—skin cancer	7.05e-05	0.00106	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—KRAS—skin cancer	7.01e-05	0.00105	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—KRAS—skin cancer	6.76e-05	0.00102	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—KRAS—skin cancer	6.7e-05	0.00101	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—CDK4—skin cancer	6.51e-05	0.000979	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—HRAS—skin cancer	6.45e-05	0.00097	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—KRAS—skin cancer	6.44e-05	0.000969	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—KRAS—skin cancer	6.44e-05	0.000969	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—IL6—skin cancer	6.37e-05	0.000959	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—KRAS—skin cancer	6.21e-05	0.000934	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—KRAS—skin cancer	6.21e-05	0.000934	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—KRAS—skin cancer	6.18e-05	0.00093	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—IL6—skin cancer	6.17e-05	0.000928	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—HRAS—skin cancer	5.96e-05	0.000896	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—NRAS—skin cancer	5.81e-05	0.000874	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—HRAS—skin cancer	5.75e-05	0.000865	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—IL6—skin cancer	5.7e-05	0.000858	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—HRAS—skin cancer	5.7e-05	0.000857	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—NRAS—skin cancer	5.56e-05	0.000836	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—IL6—skin cancer	5.5e-05	0.000828	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—HRAS—skin cancer	5.48e-05	0.000824	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—HRAS—skin cancer	5.48e-05	0.000824	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—IL6—skin cancer	5.45e-05	0.00082	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—NRAS—skin cancer	5.34e-05	0.000803	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—NRAS—skin cancer	5.34e-05	0.000803	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—HRAS—skin cancer	5.28e-05	0.000794	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—HRAS—skin cancer	5.28e-05	0.000794	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—HRAS—skin cancer	5.26e-05	0.000791	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—IL6—skin cancer	5.24e-05	0.000788	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—IL6—skin cancer	5.24e-05	0.000788	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—NRAS—skin cancer	5.15e-05	0.000775	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—NRAS—skin cancer	5.15e-05	0.000775	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—NRAS—skin cancer	5.07e-05	0.000763	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—IL6—skin cancer	5.05e-05	0.00076	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—IL6—skin cancer	5.05e-05	0.00076	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—IL6—skin cancer	5.03e-05	0.000757	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—KRAS—skin cancer	5e-05	0.000752	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—KRAS—skin cancer	4.78e-05	0.00072	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—KRAS—skin cancer	4.6e-05	0.000691	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—KRAS—skin cancer	4.6e-05	0.000691	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—KRAS—skin cancer	4.43e-05	0.000667	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—KRAS—skin cancer	4.43e-05	0.000667	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—KRAS—skin cancer	4.37e-05	0.000657	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—HRAS—skin cancer	4.25e-05	0.00064	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—IL6—skin cancer	4.07e-05	0.000612	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—HRAS—skin cancer	4.07e-05	0.000612	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—HRAS—skin cancer	3.91e-05	0.000588	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—HRAS—skin cancer	3.91e-05	0.000588	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—IL6—skin cancer	3.89e-05	0.000586	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—HRAS—skin cancer	3.77e-05	0.000567	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—HRAS—skin cancer	3.77e-05	0.000567	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—IL6—skin cancer	3.74e-05	0.000563	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—IL6—skin cancer	3.74e-05	0.000563	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—HRAS—skin cancer	3.71e-05	0.000558	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—NRAS—skin cancer	3.62e-05	0.000545	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—IL6—skin cancer	3.61e-05	0.000542	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—IL6—skin cancer	3.61e-05	0.000542	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—IL6—skin cancer	3.55e-05	0.000534	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PLIN2—skin cancer	3.28e-05	0.000494	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—KRAS—skin cancer	3.12e-05	0.000469	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—HRAS—skin cancer	2.65e-05	0.000398	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CSPG4—skin cancer	2.65e-05	0.000398	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—IL6—skin cancer	2.54e-05	0.000381	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ENO2—skin cancer	1.8e-05	0.000271	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.41e-05	0.000212	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ERCC2—skin cancer	1.05e-05	0.000157	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PTGS2—skin cancer	6.27e-06	9.43e-05	CbGpPWpGaD
